The IRD
Business Services · France · 201-500 Employees
View Company Info for Free
Overview
Headquarters
44 Boulevard De Dunkerque, Marseille, Pr...Phone Number
+33 491999200Website
www.ird.frRevenue
$18.8 MillionIndustry
About The IRD
The IRD Org Chart
Contact Centre Manager
Admin Maager
Manager, Quality Control
Responsable Administratif
Supervisor
Specialsit Investigations Team Leader
Is The IRD your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if The IRD has recently received funding, and reach out quickly before it becomes old news!
Click to see if The IRD had a recent Job posting/layoffs
The IRD, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on The IRD recently announced quarterly report
Check out if The IRD is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at The IRD
Product Launch: Get notified when The IRD launches new products
Funding: Get notified immidiatlly once The IRD has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at The IRD
Find 3 more new buyers
Company Profile Activity
Activity Insights
The IRD is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
The IRD is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about The IRD.
The IRD Tech Stack
Most Recent Scoops
The IRD News & Media
Piper Sandler Initiates Coverage on Opus Genetics, Inc. (IRD) With “Overweight” Rating and $7 PT
Opus Genetics, Inc. (NASDAQ:IRD) is one of the 12 hot penny stocks to invest in right now. On November 25, 2025, The Fly reported that Piper Sandler initiated coverage of Opus Genetics, Inc. (NASDAQ:IRD) with an “Overweight” rating and a $7 price target. The investment firm highlighted OPGx-LCA5, the company’s lead gene therapy program. The program aims […]Opus Genetics, Inc. (IRD) Discusses OPGx-LCA5 Clinical Trial Data (Transcript)
Opus Genetics shares positive early data on its LCA5 gene therapy for rare retinal diseaseIRD is learning the hard way what scams have done to trust | The Spinoff
Would you be suspicious if you received an unexpected call from the taxman?
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding The IRD
The IRD is a multidisciplinary research institute that works with partner countries on global development issues. Placed under the supervision of the French Ministry of Research and the Ministry of Foreign Affairs and International Development, the IRD uses an approach on development research and expertise throughout its international network in ov... Read More
